文献速递慢性肾脏病

肾衰竭风险方程与估算肾小球滤过率在晚期慢性肾脏病中估算进展至肾衰竭时间的效用

Utility of the Kidney Failure Risk Equation and Estimated GFR for Estimating Time to Kidney Failure in Advanced CKD.
PubMed 文献 · Am J Kidney Dis · 2023-06-08

该回顾性队列研究纳入美国34家肾脏病诊所中eGFR<60mL/min/1.73m2的1641例患者,使用加速失效时间模型估算从KFRE风险值20%、40%、50%及eGFR值20、15、10mL/min/1.73m2起始至肾衰竭的中位时间及四分位时间。在eGFR<15mL/min/1.73m2或KFRE风险>40%的患者中,KFRE风险与eGFR和肾衰竭时间的关联相似。估算晚期慢性肾脏病进展至肾衰竭的时间有助于临床决策和患者预后咨询。

要点

  • 在eGFR<15mL/min/1.73m2或KFRE风险>40%时,KFRE与eGFR和肾衰竭时间的关联相似。
  • 从eGFR 20mL/min/1.73m2起估算的至肾衰竭中位时间在不同患者特征间差异较大。
  • 估算晚期慢性肾脏病进展至肾衰竭的时间可辅助临床决策与预后咨询。

核心结论

  • 在eGFR<15mL/min/1.73m2或KFRE风险>40%的患者中,KFRE风险与eGFR和肾衰竭时间的关联相似。
  • 估算晚期慢性肾脏病进展至肾衰竭的时间有助于临床决策和患者预后咨询,无论基于eGFR还是KFRE。

研究设计与样本

  • 回顾性队列研究,数据来自CKD Outcomes and Practice Patterns Study(CKDOPPS)队列。
  • 纳入2013年至2021年美国34家肾脏病诊所中eGFR<60mL/min/1.73m2的患者,共1641例,平均年龄69±13岁,中位eGFR 28mL/min/1.73m2(IQR 20-37mL/min/1.73m2)。
  • 暴露为2年KFRE风险或eGFR;结局为肾衰竭,定义为开始透析或肾移植。
  • 采用加速失效时间(Weibull)模型估算从KFRE值20%、40%、50%及eGFR值20、15、10mL/min/1.73m2起始至肾衰竭的中位、第25百分位和第75百分位时间。

主要发现

  • 中位随访19个月(IQR 12-30个月)期间,268例发生肾衰竭,180例在肾衰竭前死亡。
  • 从eGFR 20mL/min/1.73m2起估算的至肾衰竭中位时间在不同患者特征间差异较大,年轻、男性、黑人(相较于非黑人)、糖尿病(相较于无糖尿病)、较高白蛋白尿和较高血压者时间更短。
  • 对于KFRE阈值以及eGFR 15或10mL/min/1.73m2,估算的至肾衰竭时间在这些特征间的变异性相对较小。

关键数值与推荐

  • 在eGFR<15mL/min/1.73m2或KFRE风险>40%的患者中,KFRE风险与eGFR和肾衰竭时间的关联相似。

临床怎么用

  • 原文未据此给出推荐;作者指出估算晚期慢性肾脏病进展至肾衰竭的时间可辅助临床决策和患者预后咨询,无论基于eGFR还是KFRE。

局限性

  • 估算至肾衰竭时间时无法考虑竞争风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: The Kidney Failure Risk Equation (KFRE) predicts the 2-year risk of kidney failure for patients with chronic kidney disease (CKD). Translating KFRE-predicted risk or estimated glomerular filtration rate (eGFR) into time to kidney failure could inform decision making for patients approaching kidney failure. STUDY DESIGN: Retrospective cohort. SETTING & PARTICIPANTS: CKD Outcomes and Practice Patterns Study (CKDOPPS) cohort of patients with an eGFR<60mL/min/1.73m2 from 34 US nephrology practices (2013-2021). EXPOSURE: 2-year KFRE risk or eGFR. OUTCOME: Kidney failure defined as initiation of dialysis or kidney transplantation. ANALYTICAL APPROACH: Accelerated failure time (Weibull) models used to estimate the median, 25th, and 75th percentile times to kidney failure starting from KFRE values of 20%, 40%, and 50%, and from eGFR values of 20, 15, and 10mL/min/1.73m2. We examined variability in time to kidney failure by age, sex, race, diabetes status, albuminuria, and blood pressure. RESULTS: Overall, 1,641 participants were included (mean age 69±13 years; median eGFR of 28mL/min/1.73m2 [IQR 20-37mL/min/1.73 m2]). Over a median follow-up period of 19 months (IQR, 12-30 months), 268 participants developed kidney failure, and 180 died before reaching kidney failure. The median estimated time to kidney failure was widely variable across patient characteristics from an eGFR of 20mL/min/1.73m2 and was shorter for younger age, male sex, Black (versus non-Black), diabetes (vs no diabetes), higher albuminuria, and higher blood pressure. Estimated times to kidney failure were comparably less variable across these characteristics for KFRE thresholds and eGFR of 15 or 10mL/min/1.73m2. LIMITATIONS: Inability to account for competing risks when estimating time to kidney failure. CONCLUSIONS: Among those with eGFR<15mL/min/1.73m2 or KFRE risk>40%), both KFRE risk and eGFR showed similar relationships with time to kidney failure. Our results demonstrate that estimating time to kidney failure in advanced CKD can inform clinical decisions and patient counseling on prognosis, regardless of whether estimates are based on eGFR or the KFRE. PLAIN-LANGUAGE SUMMARY: Clinicians often talk to patients with advanced chronic kidney disease about the level of kidney function expressed as the estimated glomerular filtration rate (eGFR) and about the risk of developing kidney failure, which can be estimated using the Kidney Failure Risk Equation (KFRE). In a cohort of patients with advanced chronic kidney disease, we examined how eGFR and KFRE risk predictions corresponded to the time patients had until reaching kidney failure. Among those with eGFR<15mL/min/1.73m2 or KFRE risk > 40%), both KFRE risk and eGFR showed similar relationships with time to kidney failure. Estimating time to kidney failure in advanced CKD using either eGFR or KFRE can inform clinical decisions and patient counseling on prognosis.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Chu CD, McCulloch CE, Hsu RK, et al. Utility of the Kidney Failure Risk Equation and Estimated GFR for Estimating Time to Kidney Failure in Advanced CKD. Am J Kidney Dis. 2023. PMID: 37301501. doi:10.1053/j.ajkd.2023.03.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。